nivolumabpembrolizumab
…city, with G3/4 events reported in 22% compared with 14% in the nivolumab monotherapy arm. An update presented at the European Society of…
1articles mentioning drugs
2drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: CheckMate 8HW ×
CheckMate 8HW
This drug is selected. Its supporting articles are shown below.